W81XWH22C0012

AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME"

Defense Health Agency · United States

This tender closed on Saturday, June 6, 2026. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedHealthcare & MedicalFederal

Basic information

Reference number: W81XWH22C0012
Issuing organization: Defense Health Agency · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME"
Source: USASpending (Federal)
Source ID: usa-W81XWH22C0012

Details

Location: United States

Description

AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME" Awarded to: ZYMERON CORPORATION Agency: Department of Defense Sub-agency: Defense Health Agency Award type: DEFINITIVE CONTRACT

Dates

Publication: 2022/02/07 12:00:00 AM UTC
Closing date: 2026/06/06 12:00:00 AM UTC

Estimated value

$3.0M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-05-25, 2:37:16 p.m.

Data refreshed every 2 hours